drugset / Trial / NCT04238975
A Study to Evaluate the Safety and Efficacy(Immunogenicity) of GC3111 in Healthy Adults
RandomizedParallel-groupTriple-blindPrevention
Summary
The purpose of this study is to evaluate safety and efficacy (immunogenicity) of a single dose of GC3111 versus Boostrix® vaccine among healthy adults in 19-64 years of age.
Timeline
- Start
- 2019-10-14
- Primary completion
- 2021-02
- Completion
- 2021-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Boostrix | Vaccine | 0.5 ml | Intramuscular |
| Subject | GC3111 | Vaccine | 0.5 ml | Intramuscular |